[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2025 Global IBS-C Drugs Market Research by Type, End-Use and Region (COVID-19 Version)

July 2020 | 149 pages | ID: 2049C9150B87EN
99Strategy

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global IBS-C Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:
  • Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
  • Chapter 2: Global Production & Consumption Market by Type and End-Use
  • Chapter 3: Europe Production & Consumption Market by Type and End-Use
  • Chapter 4: America Production & Consumption Market by Type and End-Use
  • Chapter 5: Asia Production & Consumption Market by Type and End-Use
  • Chapter 6: Oceania Production & Consumption Market by Type and End-Use
  • Chapter 7: Africa Production & Consumption Market by Type and End-Use
  • Chapter 8: Global Market Forecast by Type, End-Use and Region
  • Chapter 9: Company information, Sales, Cost, Margin, news etc.
  • Chapter 10: Market Competition by Companies and Market Concentration Ratio
  • Chapter 11: Market Impact by Coronavirus.
  • Chapter 12: Industry Summary
Market Segment as follows:

Key Companies
  • Catalent Pharmaceuticals Solutions
  • Nestle
  • Abbott Laboratories
  • Synergy Pharmaceuticals
  • Sucampo Pharmaceuticals
  • Novartis Pharma Ag
  • Astellas Pharmaceuticals
  • Ardelyx, Inc
  • Synthetic Biologics, Inc
  • Teva Pharmaceutical Industries
  • Bama-Geve, SLU
  • Ferring BV
  • Ironwood Pharmaceuticals, Inc
  • Salix Pharmaceuticals Ltd
  • Norgine B.V
  • Prometheus Laboratories Inc
  • Actavis Nordic A/S
  • Albireo Pharma Inc
  • Yuhan Corp
  • Astrazeneca Plc
  • The Menarini Group
  • Ono Pharmaceutical Co., Ltd
Key Types
  • Linaclotide
  • Lubiprostone
  • Osmotic Laxatives
  • Stimulant Laxatives
  • Others
Key End-Use
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
This report can be dispatched within 24-48 Hours.
CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe IBS-C Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe IBS-C Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America IBS-C Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America IBS-C Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia IBS-C Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaIBS-C Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania IBS-C Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania IBS-C Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa IBS-C Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa IBS-C Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global IBS-C Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global IBS-C Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Global IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Table Global IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Global IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Global IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe IBS-C Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe IBS-C Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Europe IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Table Europe IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Europe IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America IBS-C Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America IBS-C Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Figure America IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Table America IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Figure America IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table America IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia IBS-C Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia IBS-C Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Asia IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Table Asia IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Asia IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania IBS-C Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania IBS-C Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Oceania IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Table Oceania IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Oceania IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa IBS-C Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa IBS-C Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Africa IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Table Africa IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Africa IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global IBS-C Drugs Production Forecast
Figure Global IBS-C Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global IBS-C Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global IBS-C Drugs Forecast by Type
Table Global IBS-C Drugs Revenue by Type, 2020E-2025F (Million USD)
Figure Global IBS-C Drugs Revenue Share by Type in 2025 (Million USD)
Table Global IBS-C Drugs Production Volume by Type, 2020E-2025F (Volume)
Figure Global IBS-C Drugs Production Volume Share by Type in 2025 (Volume)
8.3 Global IBS-C Drugs Forecast by End-Use (2020E-2025F)
Table Global IBS-C Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global IBS-C Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Table Global IBS-C Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global IBS-C Drugs Forecast by Region (2020E-2025F)
Table Global IBS-C Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global IBS-C Drugs Consumption Value Share by Region in 2025 (Million USD)
Table Global IBS-C Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global IBS-C Drugs Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Catalent Pharmaceuticals Solutions
  9.1.1 Catalent Pharmaceuticals Solutions Profile
Table Catalent Pharmaceuticals Solutions Overview List
  9.1.2 Catalent Pharmaceuticals Solutions Products & Services
  9.1.3 Catalent Pharmaceuticals Solutions Company Dynamics & News
  9.1.4 Catalent Pharmaceuticals Solutions Business Operation Conditions
Table Business Operation of Catalent Pharmaceuticals Solutions (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Nestle
  9.2.1 Nestle Profile
Table Nestle Overview List
  9.2.2 Nestle Products & Services
  9.2.3 Nestle Company Dynamics & News
  9.2.4 Nestle Business Operation Conditions
Table Business Operation of Nestle (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Abbott Laboratories
  9.3.1 Abbott Laboratories Profile
Table Abbott Laboratories Overview List
  9.3.2 Abbott Laboratories Products & Services
  9.3.3 Abbott Laboratories Company Dynamics & News
  9.3.4 Abbott Laboratories Business Operation Conditions
Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Synergy Pharmaceuticals
  9.4.1 Synergy Pharmaceuticals Profile
Table Synergy Pharmaceuticals Overview List
  9.4.2 Synergy Pharmaceuticals Products & Services
  9.4.3 Synergy Pharmaceuticals Company Dynamics & News
  9.4.4 Synergy Pharmaceuticals Business Operation Conditions
Table Business Operation of Synergy Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Sucampo Pharmaceuticals
  9.5.1 Sucampo Pharmaceuticals Profile
Table Sucampo Pharmaceuticals Overview List
  9.5.2 Sucampo Pharmaceuticals Products & Services
  9.5.3 Sucampo Pharmaceuticals Company Dynamics & News
  9.5.4 Sucampo Pharmaceuticals Business Operation Conditions
Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Novartis Pharma Ag
  9.6.1 Novartis Pharma Ag Profile
Table Novartis Pharma Ag Overview List
  9.6.2 Novartis Pharma Ag Products & Services
  9.6.3 Novartis Pharma Ag Company Dynamics & News
  9.6.4 Novartis Pharma Ag Business Operation Conditions
Table Business Operation of Novartis Pharma Ag (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Astellas Pharmaceuticals
  9.7.1 Astellas Pharmaceuticals Profile
Table Astellas Pharmaceuticals Overview List
  9.7.2 Astellas Pharmaceuticals Products & Services
  9.7.3 Astellas Pharmaceuticals Company Dynamics & News
  9.7.4 Astellas Pharmaceuticals Business Operation Conditions
Table Business Operation of Astellas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Ardelyx, Inc
  9.8.1 Ardelyx, Inc Profile
Table Ardelyx, Inc Overview List
  9.8.2 Ardelyx, Inc Products & Services
  9.8.3 Ardelyx, Inc Company Dynamics & News
  9.8.4 Ardelyx, Inc Business Operation Conditions
Table Business Operation of Ardelyx, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Synthetic Biologics, Inc
  9.9.1 Synthetic Biologics, Inc Profile
Table Synthetic Biologics, Inc Overview List
  9.9.2 Synthetic Biologics, Inc Products & Services
  9.9.3 Synthetic Biologics, Inc Company Dynamics & News
  9.9.4 Synthetic Biologics, Inc Business Operation Conditions
Table Business Operation of Synthetic Biologics, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Teva Pharmaceutical Industries
  9.10.1 Teva Pharmaceutical Industries Profile
Table Teva Pharmaceutical Industries Overview List
  9.10.2 Teva Pharmaceutical Industries Products & Services
  9.10.3 Teva Pharmaceutical Industries Company Dynamics & News
  9.10.4 Teva Pharmaceutical Industries Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Bama-Geve, SLU
  9.11.1 Bama-Geve, SLU Profile
Table Bama-Geve, SLU Overview List
  9.11.2 Bama-Geve, SLU Products & Services
  9.11.3 Bama-Geve, SLU Company Dynamics & News
  9.11.4 Bama-Geve, SLU Business Operation Conditions
Table Business Operation of Bama-Geve, SLU (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Ferring BV
  9.12.1 Ferring BV Profile
Table Ferring BV Overview List
  9.12.2 Ferring BV Products & Services
  9.12.3 Ferring BV Company Dynamics & News
  9.12.4 Ferring BV Business Operation Conditions
Table Business Operation of Ferring BV (Sales Revenue, Cost, Gross Margin)
9.13 Ironwood Pharmaceuticals, Inc
  9.13.1 Ironwood Pharmaceuticals, Inc Profile
Table Ironwood Pharmaceuticals, Inc Overview List
  9.13.2 Ironwood Pharmaceuticals, Inc Products & Services
  9.13.3 Ironwood Pharmaceuticals, Inc Company Dynamics & News
  9.13.4 Ironwood Pharmaceuticals, Inc Business Operation Conditions
Table Business Operation of Ironwood Pharmaceuticals, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Salix Pharmaceuticals Ltd
  9.14.1 Salix Pharmaceuticals Ltd Profile
Table Salix Pharmaceuticals Ltd Overview List
  9.14.2 Salix Pharmaceuticals Ltd Products & Services
  9.14.3 Salix Pharmaceuticals Ltd Company Dynamics & News
  9.14.4 Salix Pharmaceuticals Ltd Business Operation Conditions
Table Business Operation of Salix Pharmaceuticals Ltd (Sales Revenue, Cost, Gross Margin)
9.15 Norgine B.V
  9.15.1 Norgine B.V Profile
Table Norgine B.V Overview List
  9.15.2 Norgine B.V Products & Services
  9.15.3 Norgine B.V Company Dynamics & News
  9.15.4 Norgine B.V Business Operation Conditions
Table Business Operation of Norgine B.V (Sales Revenue, Cost, Gross Margin)
9.16 Prometheus Laboratories Inc
  9.16.1 Prometheus Laboratories Inc Profile
Table Prometheus Laboratories Inc Overview List
  9.16.2 Prometheus Laboratories Inc Products & Services
  9.16.3 Prometheus Laboratories Inc Company Dynamics & News
  9.16.4 Prometheus Laboratories Inc Business Operation Conditions
Table Business Operation of Prometheus Laboratories Inc (Sales Revenue, Cost, Gross Margin)
9.17 Actavis Nordic A/S
  9.17.1 Actavis Nordic A/S Profile
Table Actavis Nordic A/S Overview List
  9.17.2 Actavis Nordic A/S Products & Services
  9.17.3 Actavis Nordic A/S Company Dynamics & News
  9.17.4 Actavis Nordic A/S Business Operation Conditions
Table Business Operation of Actavis Nordic A/S (Sales Revenue, Cost, Gross Margin)
9.18 Albireo Pharma Inc
  9.18.1 Albireo Pharma Inc Profile
Table Albireo Pharma Inc Overview List
  9.18.2 Albireo Pharma Inc Products & Services
  9.18.3 Albireo Pharma Inc Company Dynamics & News
  9.18.4 Albireo Pharma Inc Business Operation Conditions
Table Business Operation of Albireo Pharma Inc (Sales Revenue, Cost, Gross Margin)
9.19 Yuhan Corp
  9.19.1 Yuhan Corp Profile
Table Yuhan Corp Overview List
  9.19.2 Yuhan Corp Products & Services
  9.19.3 Yuhan Corp Company Dynamics & News
  9.19.4 Yuhan Corp Business Operation Conditions
Table Business Operation of Yuhan Corp (Sales Revenue, Cost, Gross Margin)
9.20 Astrazeneca Plc
  9.20.1 Astrazeneca Plc Profile
Table Astrazeneca Plc Overview List
  9.20.2 Astrazeneca Plc Products & Services
  9.20.3 Astrazeneca Plc Company Dynamics & News
  9.20.4 Astrazeneca Plc Business Operation Conditions
Table Business Operation of Astrazeneca Plc (Sales Revenue, Cost, Gross Margin)
9.21 The Menarini Group
  9.21.1 The Menarini Group Profile
Table The Menarini Group Overview List
  9.21.2 The Menarini Group Products & Services
  9.21.3 The Menarini Group Company Dynamics & News
  9.21.4 The Menarini Group Business Operation Conditions
Table Business Operation of The Menarini Group (Sales Revenue, Cost, Gross Margin)
9.22 Ono Pharmaceutical Co., Ltd
  9.22.1 Ono Pharmaceutical Co., Ltd Profile
Table Ono Pharmaceutical Co., Ltd Overview List
  9.22.2 Ono Pharmaceutical Co., Ltd Products & Services
  9.22.4 Ono Pharmaceutical Co., Ltd Business Operation Conditions
Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global IBS-C Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global IBS-C Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global IBS-C Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global IBS-C Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe IBS-C Drugs Market Concentration Ratio in 2020E
Figure America IBS-C Drugs Market Concentration Ratio in 2020E
Figure Asia IBS-C Drugs Market Concentration Ratio in 2020E
Figure Oceania IBS-C Drugs Market Concentration Ratio in 2020E
Figure Africa IBS-C Drugs Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON IBS-C DRUGS INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 IBS-C DRUGS INDUSTRY SUMMARY & CONCLUSION
LIST OF TABLES
Table Global IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Table Global IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Table Global IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Europe IBS-C Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe IBS-C Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Table Europe IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Table Europe IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table America IBS-C Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America IBS-C Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Table America IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Table America IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table America IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table America IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Asia IBS-C Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia IBS-C Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Table Asia IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Table Asia IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania IBS-C Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania IBS-C Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Table Oceania IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Table Oceania IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Africa IBS-C Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa IBS-C Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa IBS-C Drugs Revenue by Type, 2015-2020 (Million USD)
Table Africa IBS-C Drugs Production Volume by Type, 2015-2020 (Volume)
Table Africa IBS-C Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa IBS-C Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa IBS-C Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa IBS-C Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Global IBS-C Drugs Revenue by Type, 2020E-2025F (Million USD)
Table Global IBS-C Drugs Production Volume by Type, 2020E-2025F (Volume)
Table Global IBS-C Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global IBS-C Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global IBS-C Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Table Global IBS-C Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Table Catalent Pharmaceuticals Solutions  Overview List
Table Business Operation of Catalent Pharmaceuticals Solutions  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nestle  Overview List
Table Business Operation of Nestle  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Laboratories  Overview List
Table Business Operation of Abbott Laboratories  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Synergy Pharmaceuticals  Overview List
Table Business Operation of Synergy Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sucampo Pharmaceuticals  Overview List
Table Business Operation of Sucampo Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Pharma Ag  Overview List
Table Business Operation of Novartis Pharma Ag  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Pharmaceuticals  Overview List
Table Business Operation of Astellas Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ardelyx, Inc  Overview List
Table Business Operation of Ardelyx, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Synthetic Biologics, Inc  Overview List
Table Business Operation of Synthetic Biologics, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries  Overview List
Table Business Operation of Teva Pharmaceutical Industries  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bama-Geve, SLU  Overview List
Table Business Operation of Bama-Geve, SLU  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ferring BV  Overview List
Table Business Operation of Ferring BV  (Sales Revenue, Cost, Gross Margin)
Table Ironwood Pharmaceuticals, Inc  Overview List
Table Business Operation of Ironwood Pharmaceuticals, Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Salix Pharmaceuticals Ltd  Overview List
Table Business Operation of Salix Pharmaceuticals Ltd  (Sales Revenue, Cost, Gross Margin)
Table Norgine B.V  Overview List
Table Business Operation of Norgine B.V  (Sales Revenue, Cost, Gross Margin)
Table Prometheus Laboratories Inc  Overview List
Table Business Operation of Prometheus Laboratories Inc  (Sales Revenue, Cost, Gross Margin)
Table Actavis Nordic A/S  Overview List
Table Business Operation of Actavis Nordic A/S  (Sales Revenue, Cost, Gross Margin)
Table Albireo Pharma Inc  Overview List
Table Business Operation of Albireo Pharma Inc  (Sales Revenue, Cost, Gross Margin)
Table Yuhan Corp  Overview List
Table Business Operation of Yuhan Corp  (Sales Revenue, Cost, Gross Margin)
Table Astrazeneca Plc  Overview List
Table Business Operation of Astrazeneca Plc  (Sales Revenue, Cost, Gross Margin)
Table The Menarini Group  Overview List
Table Business Operation of The Menarini Group  (Sales Revenue, Cost, Gross Margin)
Table Ono Pharmaceutical Co., Ltd Overview List
Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Cost, Gross Margin)
Table Global IBS-C Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global IBS-C Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global IBS-C Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global IBS-C Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
LIST OF FIGURES
Figure Europe IBS-C Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe IBS-C Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America IBS-C Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America IBS-C Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia IBS-C Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaIBS-C Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania IBS-C Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania IBS-C Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa IBS-C Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa IBS-C Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Figure Global IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
Figure Global IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Figure Europe IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
Figure Europe IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure America IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Figure America IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
Figure America IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure America IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Figure Asia IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
Figure Asia IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Figure Oceania IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
Figure Oceania IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa IBS-C Drugs Revenue Share by Type in 2020 (Million USD)
Figure Africa IBS-C Drugs Production Volume Share by Type in 2020 (Volume)
Figure Africa IBS-C Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa IBS-C Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global IBS-C Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global IBS-C Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global IBS-C Drugs Revenue Share by Type in 2025 (Million USD)
Figure Global IBS-C Drugs Production Volume Share by Type in 2025 (Volume)
Figure Global IBS-C Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global IBS-C Drugs Consumption Value Share by Region in 2025 (Million USD)
Figure Global IBS-C Drugs Consumption Volume Share by Region in 2025 (Volume)


More Publications